Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TP53 |
Variant | E224fs |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | TP53 E224fs results in a change in the amino acid sequence of the Tp53 protein beginning at aa 224 of 393, likely resulting in premature truncation of the functional protein (UniProt.org). E224fs has not been biochemically characterized however, due to the effects of truncation mutations downstream of E224 (PMID: 31081129, PMID: 34045312), is predicted to lead to a loss of Tp53 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
TP53 mutant TP53 exon6 TP53 E224fs TP53 mutant TP53 inact mut TP53 E224fs |
Transcript | NM_000546.6 |
gDNA | chr17:g.(7674861_7674862) |
cDNA | c.(670_669) |
Protein | p.E224fs |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001126114 | chr17:g.(7674861_7674862) | c.(670_669) | p.E224fs | RefSeq | GRCh38/hg38 |
NM_001407264.1 | chr17:g.(7674861_7674862) | c.(670_669) | p.E224fs | RefSeq | GRCh38/hg38 |
NM_001126113.3 | chr17:g.(7674861_7674862) | c.(670_669) | p.E224fs | RefSeq | GRCh38/hg38 |
NM_001126112.3 | chr17:g.(7674861_7674862) | c.(670_669) | p.E224fs | RefSeq | GRCh38/hg38 |
NM_001126112.2 | chr17:g.(7674861_7674862) | c.(670_669) | p.E224fs | RefSeq | GRCh38/hg38 |
NM_001407268.1 | chr17:g.(7674861_7674862) | c.(670_669) | p.E224fs | RefSeq | GRCh38/hg38 |
NM_000546.5 | chr17:g.(7674861_7674862) | c.(670_669) | p.E224fs | RefSeq | GRCh38/hg38 |
NM_000546.6 | chr17:g.(7674861_7674862) | c.(670_669) | p.E224fs | RefSeq | GRCh38/hg38 |
NM_001126113 | chr17:g.(7674861_7674862) | c.(670_669) | p.E224fs | RefSeq | GRCh38/hg38 |
NM_001126114.3 | chr17:g.(7674861_7674862) | c.(670_669) | p.E224fs | RefSeq | GRCh38/hg38 |
NM_001126112 | chr17:g.(7674861_7674862) | c.(670_669) | p.E224fs | RefSeq | GRCh38/hg38 |
NM_001407266.1 | chr17:g.(7674861_7674862) | c.(670_669) | p.E224fs | RefSeq | GRCh38/hg38 |
NM_001407262.1 | chr17:g.(7674861_7674862) | c.(670_669) | p.E224fs | RefSeq | GRCh38/hg38 |
NM_000546 | chr17:g.(7674861_7674862) | c.(670_669) | p.E224fs | RefSeq | GRCh38/hg38 |
NM_001126113.2 | chr17:g.(7674861_7674862) | c.(670_669) | p.E224fs | RefSeq | GRCh38/hg38 |
NM_001407270.1 | chr17:g.(7674861_7674862) | c.(670_669) | p.E224fs | RefSeq | GRCh38/hg38 |
NM_001126114.2 | chr17:g.(7674861_7674862) | c.(670_669) | p.E224fs | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|